Lutjohann D, Breuer O, Ahlborg G et al. Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation. Proc Natl Acad Sci U S A 1996; 93: 9799-9804.
Lund EG, Guileyardo JM, Russell DW. cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain. Proc Natl Acad Sci U S A 1999; 96: 7238-7243.
Bjorkhem I, Lutjohann D, Diczfalusy U, Stahle L, Ahlborg G, Wahren J. Cholesterol homeostasis in human brain: turnover of 24S-hydroxycholesterol and evidence for a cerebral origin of most of this oxysterol in the circulation. J Lipid Res 1998; 39: 1594-1600.
Hudry E, Van Dam D, Kulik W et al. Adeno-associated virus gene therapy with cholesterol 24-hydroxylase reduces the amyloid pathology before or after the onset of amyloid plaques in mouse models of Alzheimer's disease. Mol Ther 2010; 18: 44-53.
Burlot MA, Braudeau J, Michaelsen-Preusse K et al. Cholesterol 24-hydroxylase defect is implicated in memory impairments associated with Alzheimer-like Tau pathology. Hum Mol Genet 2015; 24: 5965-5976.
Boussicault L, Alves S, Lamaziere A et al. CYP46A1, the rate-limiting enzyme for cholesterol degradation, is neuroprotective in Huntington's disease. Brain 2016; 139: 953-970.
Mast N, Saadane A, Valencia-Olvera A et al. Cholesterol-metabolizing enzyme cytochrome P450 46A1 as a pharmacologic target for Alzheimer's disease. Neuropharmacology 2017; 123: 465-476.
Patel TK, Patel VB, Rana DG. Possible anti-depressant effect of efavirenz and pro-depressive-like effect of voriconazole in specified doses in various experimental models of depression in mice. Pharmacol Rep 2017; 69: 1082-1087.
Han M, Wang S, Yang N et al. Therapeutic implications of altered cholesterol homeostasis mediated by loss of CYP46A1 in human glioblastoma. EMBO Mol Med 2019: e10924.
Kacher R, Lamaziere A, Heck N et al. CYP46A1 gene therapy deciphers the role of brain cholesterol metabolism in Huntington's disease. Brain 2019; 142: 2432-2450.
Mitroi DN, Pereyra-Gomez G, Soto-Huelin B et al. NPC1 enables cholesterol mobilization during long-term potentiation that can be restored in Niemann-Pick disease type C by CYP46A1 activation. EMBO Rep 2019: e48143.
Nobrega C, Mendonca L, Marcelo A et al. Restoring brain cholesterol turnover improves autophagy and has therapeutic potential in mouse models of spinocerebellar ataxia. Acta Neuropathol 2019.
Petrov AM, Lam M, Mast N et al. CYP46A1 activation by efavirenz leads to behavioral improvement without significant changes in amyloid plaque load in the brain of 5XFAD mice. Neurotherapeutics 2019; 16: 710-724.
Ali T, Hannaoui S, Nemani S et al. Oral administration of repurposed drug targeting Cyp46A1 increases survival times of prion infected mice. Acta Neuropathol Commun 2021; 9: 58.
Bialer M, Johannessen SI, Koepp MJ et al. Progress report on new antiepileptic drugs: A summary of the Fourteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIV). I. Drugs in preclinical and early clinical development. Epilepsia 2018; 59: 1811–1841.
Mast N, Li Y, Linger M, Clark M, Wiseman J, Pikuleva IA. Pharmacologic stimulation of cytochrome P450 46A1 and cerebral cholesterol turnover in mice. J Biol Chem 2014; 289: 3529-3538.
Oakley H, Cole SL, Logan S et al. Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation. J Neurosci 2006; 26: 10129-10140.
Petrov AM, Mast N, Li Y, Pikuleva IA. The key genes, phosphoproteins, processes, and pathways affected by efavirenz-activated CYP46A1 in the amyloid-decreasing paradigm of efavirenz treatment. FASEB J 2019; 33: 8782-8798.
Nishi T, Kondo S, Miyamoto M et al. Soticlestat, a novel cholesterol 24-hydroxylase inhibitor shows a therapeutic potential for neural hyperexcitation in mice. Sci Rep 2020; 10: 17081.
Petrov AM, Mast N, Li Y, Denker J, Pikuleva IA. Brain sterol flux mediated by cytochrome P450 46A1 affects membrane properties and membrane-dependent processes. Brain Commun 2020; 2.
The UniProt C. UniProt: a hub for protein information. Nucleic Acids Research 2015; 43: D204-D212.
Mast N, Lin JB, Anderson KW, Bjorkhem I, Pikuleva IA. Transcriptional and post-translational changes in the brain of mice deficient in cholesterol removal mediated by cytochrome P450 46A1 (CYP46A1). PLoS One 2017; 12: e0187168.
Hu YT, Boonstra J, McGurran H et al. Sex differences in the neuropathological hallmarks of Alzheimer's disease: focus on cognitively intact elderly individuals. Neuropathol Appl Neurobiol 2021.
Guo L, Zhong MB, Zhang L, Zhang B, Cai D. Sex Differences in Alzheimer's Disease: Insights From the Multiomics Landscape. Biol Psychiatry 2021.
Doellinger J, Schneider A, Hoeller M, Lasch P. Sample Preparation by Easy Extraction and Digestion (SPEED) - A Universal, Rapid, and Detergent-free Protocol for Proteomics Based on Acid Extraction. Molecular & Cellular Proteomics 2020; 19: 209.
Nickerson JL, Doucette AA. Rapid and Quantitative Protein Precipitation for Proteome Analysis by Mass Spectrometry. Journal of Proteome Research 2020; 19: 2035-2042.
Moggridge S, Sorensen PH, Morin GB, Hughes CS. Extending the Compatibility of the SP3 Paramagnetic Bead Processing Approach for Proteomics. Journal of Proteome Research 2018; 17: 1730-1740.
Searle BC, Pino LK, Egertson JD et al. Chromatogram libraries improve peptide detection and quantification by data independent acquisition mass spectrometry. Nature Communications 2018; 9: 5128.
Chambers MC, Maclean B, Burke R et al. A cross-platform toolkit for mass spectrometry and proteomics. Nat Biotechnol 2012; 30: 918-920.
Sturm M, Bertsch A, Gropl C et al. OpenMS - an open-source software framework for mass spectrometry. BMC Bioinformatics 2008; 9: 163.
Craig R, Beavis RC. TANDEM: matching proteins with tandem mass spectra. Bioinformatics 2004; 20: 1466-1467.
Eng JK, Jahan TA, Hoopmann MR. Comet: an open-source MS/MS sequence database search tool. Proteomics 2013; 13: 22-24.
Frewen B, MacCoss MJ. Using BiblioSpec for Creating and Searching Tandem MS Peptide Libraries. Current Protocols in Bioinformatics 2007; 20: 13.17.11–13.17.12.
Slotta DJ, McFarland MA, Markey SP. MassSieve: Panning MS/MS peptide data for proteins. PROTEOMICS 2010; 10: 3035-3039.
Ammar C, Gruber M, Csaba G, Zimmer R. MS-EmpiRe Utilizes Peptide-level Noise Distributions for Ultra-sensitive Detection of Differentially Expressed Proteins. Molecular & Cellular Proteomics 2019; 18: 1880.
Sims NR, Anderson MF. Isolation of mitochondria from rat brain using Percoll density gradient centrifugation. Nat Protoc 2008; 3: 1228-1239.
Szklarczyk D, Gable AL, Lyon D et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res 2019; 47: D607-d613.
Pietrocola F, Galluzzi L, Bravo-San Pedro JM, Madeo F, Kroemer G. Acetyl coenzyme A: a central metabolite and second messenger. Cell Metab 2015; 21: 805-821.
Webb BA, Forouhar F, Szu F-E, Seetharaman J, Tong L, Barber DL. Structures of human phosphofructokinase-1 and atomic basis of cancer-associated mutations. Nature 2015; 523: 111-114.
Benarroch EE. Brain glucose transporters. Neurology 2014; 82: 1374.
El-Darzi N, Mast N, Petrov AM et al. Studies of ApoD(-/-) and ApoD(-/-)ApoE(-/-) mice uncover the APOD significance for retinal metabolism, function, and status of chorioretinal blood vessels. Cell Mol Life Sci 2021; 78: 963-983.
Ronowska A, Szutowicz A, Bielarczyk H et al. The Regulatory Effects of Acetyl-CoA Distribution in the Healthy and Diseased Brain. Front Cell Neurosci 2018; 12: 169.
Miziorko HM. Enzymes of the mevalonate pathway of isoprenoid biosynthesis. Arch Biochem Biophys 2011; 505: 131-143.
Pfrieger FW. Cholesterol homeostasis and function in neurons of the central nervous system. Cell Mol Life Sci 2003; 60: 1158-1171.
Lund EG, Xie C, Kotti T, Turley SD, Dietschy JM, Russell DW. Knockout of the cholesterol 24-hydroxylase gene in mice reveals a brain-specific mechanism of cholesterol turnover. J Biol Chem 2003; 278: 22980-22988.
Repa JJ, Mangelsdorf DJ. The role of orphan nuclear receptors in the regulation of cholesterol homeostasis. Annu Rev Cell Dev Biol 2000; 16: 459-481.
Brown MS, Goldstein JL. Cholesterol feedback: from Schoenheimer's bottle to Scap's MELADL. J Lipid Res 2009; 50 Suppl: S15-27.
Meaney S. Epigenetic regulation of cholesterol homeostasis. Front Genet 2014; 5: 311.
Hoyer S. Memory function and brain glucose metabolism. Pharmacopsychiatry 2003; 36 Suppl 1: S62-67.
Kotti TJ, Ramirez DM, Pfeiffer BE, Huber KM, Russell DW. Brain cholesterol turnover required for geranylgeraniol production and learning in mice. Proc Natl Acad Sci U S A 2006; 103: 3869-3874.
Kotti T, Head DD, McKenna CE, Russell DW. Biphasic requirement for geranylgeraniol in hippocampal long-term potentiation. Proc Natl Acad Sci U S A 2008; 105: 11394-11399.
Choudhary C, Weinert BT, Nishida Y, Verdin E, Mann M. The growing landscape of lysine acetylation links metabolism and cell signalling. Nat Rev Mol Cell Biol 2014; 15: 536-550.
Francis PT. The interplay of neurotransmitters in Alzheimer's disease. CNS Spectr 2005; 10: 6-9.
Ferreira-Vieira TH, Guimaraes IM, Silva FR, Ribeiro FM. Alzheimer's disease: Targeting the Cholinergic System. Current neuropharmacology 2016; 14: 101-115.
Takahashi H, McCaffery JM, Irizarry RA, Boeke JD. Nucleocytosolic acetyl-coenzyme a synthetase is required for histone acetylation and global transcription. Mol Cell 2006; 23: 207-217.
Wellen KE, Hatzivassiliou G, Sachdeva UM, Bui TV, Cross JR, Thompson CB. ATP-citrate lyase links cellular metabolism to histone acetylation. Science 2009; 324: 1076-1080.
Drummond E, Pires G, MacMurray C et al. Phosphorylated tau interactome in the human Alzheimer's disease brain. Brain 2020; 143: 2803-2817.
Goellner B, Aberle H. The synaptic cytoskeleton in development and disease. Developmental Neurobiology 2012; 72: 111-125.
Lanciotti A, Brignone MS, Molinari P et al. Megalencephalic leukoencephalopathy with subcortical cysts protein 1 functionally cooperates with the TRPV4 cation channel to activate the response of astrocytes to osmotic stress: dysregulation by pathological mutations. Hum Mol Genet 2012; 21: 2166-2180.
López-Marqués RL, Gourdon P, Günther Pomorski T, Palmgren M. The transport mechanism of P4 ATPase lipid flippases. Biochem J 2020; 477: 3769-3790.
Honigmann A, van den Bogaart G, Iraheta E et al. Phosphatidylinositol 4,5-bisphosphate clusters act as molecular beacons for vesicle recruitment. Nat Struct Mol Biol 2013; 20: 679-686.
Lira M, Mira RG, Carvajal FJ, Zamorano P, Inestrosa NC, Cerpa W. Glutamatergic Receptor Trafficking and Delivery: Role of the Exocyst Complex. Cells 2020; 9.
Fernández-Chacón R, Königstorfer A, Gerber SH et al. Synaptotagmin I functions as a calcium regulator of release probability. Nature 2001; 410: 41-49.
Davletov B, Sontag JM, Hata Y et al. Phosphorylation of synaptotagmin I by casein kinase II. J Biol Chem 1993; 268: 6816-6822.
Liang T, Sang S, Shao Q et al. Abnormal expression and prognostic significance of EPB41L1 in kidney renal clear cell carcinoma based on data mining. Cancer Cell Int 2020; 20: 356.
Han X, Wang X, Li H, Zhang H. Mechanism of microRNA-431-5p-EPB41L1 interaction in glioblastoma multiforme cells. Arch Med Sci 2019; 15: 1555-1564.
Medina M, Marinescu RC, Overhauser J, Kosik KS. Hemizygosity of delta-catenin (CTNND2) is associated with severe mental retardation in cri-du-chat syndrome. Genomics 2000; 63: 157-164.
Lu Q, Aguilar BJ, Li M, Jiang Y, Chen YH. Genetic alterations of δ-catenin/NPRAP/Neurojungin (CTNND2): functional implications in complex human diseases. Hum Genet 2016; 135: 1107-1116.
Gingras AC, Raught B, Sonenberg N. eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation. Annu Rev Biochem 1999; 68: 913-963.
García-García C, Frieda KL, Feoktistova K, Fraser CS, Block SM. Factor-dependent processivity in human eIF4A DEAD-box helicase. Science 2015; 348: 1486-1488.
Shahbazian D, Parsyan A, Petroulakis E, Hershey J, Sonenberg N. eIF4B controls survival and proliferation and is regulated by proto-oncogenic signaling pathways. Cell Cycle 2010; 9: 4106-4109.
Hotta A, Kawakatsu T, Nakatani T et al. Laminin-based cell adhesion anchors microtubule plus ends to the epithelial cell basal cortex through LL5alpha/beta. J Cell Biol 2010; 189: 901-917.
Sala K, Raimondi A, Tonoli D, Tacchetti C, de Curtis I. Identification of a membrane-less compartment regulating invadosome function and motility. Sci Rep 2018; 8: 1164.
Viana-Pereira M, Moreno DA, Linhares P et al. Replication of GWAS identifies RTEL1, CDKN2A/B, and PHLDB1 SNPs as risk factors in Portuguese gliomas patients. Mol Biol Rep 2020; 47: 877-886.
Di Stefano P, Damiano L, Cabodi S et al. p140Cap protein suppresses tumour cell properties, regulating Csk and Src kinase activity. The EMBO Journal 2007; 26: 2843-2855.
Krishnan R, Boddapati N, Mahalingam S. Interplay between human nucleolar GNL1 and RPS20 is critical to modulate cell proliferation. Sci Rep 2018; 8: 11421.
Schonkeren SL, Massen M, van der Horst R, Koch A, Vaes N, Melotte V. Nervous NDRGs: the N-myc downstream-regulated gene family in the central and peripheral nervous system. Neurogenetics 2019; 20: 173-186.
Tennstedt P, Bölch C, Strobel G et al. Patterns of TPD52 overexpression in multiple human solid tumor types analyzed by quantitative PCR. Int J Oncol 2014; 44: 609-615.
Boutros R, Fanayan S, Shehata M, Byrne JA. The tumor protein D52 family: many pieces, many puzzles. Biochem Biophys Res Commun 2004; 325: 1115-1121.
Chevet E, Smirle J, Cameron PH, Thomas DY, Bergeron JJ. Calnexin phosphorylation: linking cytoplasmic signalling to endoplasmic reticulum lumenal functions. Semin Cell Dev Biol 2010; 21: 486-490.
Oh M, Kim H, Yang I et al. GSK-3 phosphorylates delta-catenin and negatively regulates its stability via ubiquitination/proteosome-mediated proteolysis. J Biol Chem 2009; 284: 28579-28589.
Moutal A, White KA, Chefdeville A et al. Dysregulation of CRMP2 Post-Translational Modifications Drive Its Pathological Functions. Mol Neurobiol 2019; 56: 6736-6755.
Bettegazzi B, Bellani S, Roncon P et al. eIF4B phosphorylation at Ser504 links synaptic activity with protein translation in physiology and pathology. Sci Rep 2017; 7: 10563.
Holahan MR. A Shift from a Pivotal to Supporting Role for the Growth-Associated Protein (GAP-43) in the Coordination of Axonal Structural and Functional Plasticity. Front Cell Neurosci 2017; 11: 266.
Riederer BM. Microtubule-associated protein 1B, a growth-associated and phosphorylated scaffold protein. Brain Res Bull 2007; 71: 541-558.
Tapia-Rojas C, Cabezas-Opazo F, Deaton CA, Vergara EH, Johnson GVW, Quintanilla RA. It’s all about tau. Prog Neurobiol 2019; 175: 54-76.
Veeranna, Shetty KT, Link WT, Jaffe H, Wang J, Pant HC. Neuronal cyclin-dependent kinase-5 phosphorylation sites in neurofilament protein (NF-H) are dephosphorylated by protein phosphatase 2A. J Neurochem 1995; 64: 2681–2690.
Veeranna, Amin ND, Ahn NG et al. Mitogen-activated protein kinases (Erk1,2) phosphorylate Lys-Ser-Pro (KSP) repeats in neurofilament proteins NF-H and NF-M. J Neurosci 1998; 18: 4008–4021.
Veeranna, Yang DS, Lee JH et al. Declining phosphatases underlie aging-related hyperphosphorylation of neurofilaments. Neurobiol Aging 2011; 32: 2016–2029.
Hilfiker S, Pieribone VA, Nordstedt C, Greengard P, Czernik AJ. Regulation of synaptotagmin I phosphorylation by multiple protein kinases. J Neurochem 1999; 73: 921-932.
Nagy G, Kim JH, Pang ZP et al. Different effects on fast exocytosis induced by synaptotagmin 1 and 2 isoforms and abundance but not by phosphorylation. J Neurosci 2006; 26: 632-643.
Mast N, El-Darzi N, Petrov AM, Li Y, Pikuleva IA. CYP46A1-dependent and independent effects of efavirenz treatment. Brain Commun 2020; 2: fcaa180.
Yuan A, Rao MV, Veeranna, Nixon RA. Neurofilaments and Neurofilament Proteins in Health and Disease. Cold Spring Harb Perspect Biol 2017; 9.
Guarguaglini G, Duncan PI, Stierhof YD, Holmstrom T, Duensing S, Nigg EA. The forkhead-associated domain protein Cep170 interacts with Polo-like kinase 1 and serves as a marker for mature centrioles. Mol Biol Cell 2005; 16: 1095-1107.
Ramkumar A, Jong BY, Ori-McKenney KM. ReMAPping the microtubule landscape: How phosphorylation dictates the activities of microtubule-associated proteins. Dev Dyn 2018; 247: 138-155.
Sánchez C, Díaz-Nido J, Avila J. Phosphorylation of microtubule-associated protein 2 (MAP2) and its relevance for the regulation of the neuronal cytoskeleton function. Prog Neurobiol 2000; 61: 133-168.
Ishikawa Y, Okada M, Honda A et al. Phosphorylation sites of microtubule-associated protein 1B (MAP 1B) are involved in axon growth and regeneration. Mol Brain 2019; 12: 93.
Hensley K, Venkova K, Christov A, Gunning W, Park J. Collapsin response mediator protein-2: an emerging pathologic feature and therapeutic target for neurodisease indications. Mol Neurobiol 2011; 43: 180-191.
Martins-de-Souza D, Cassoli JS, Nascimento JM et al. The protein interactome of collapsin response mediator protein-2 (CRMP2/DPYSL2) reveals novel partner proteins in brain tissue. Proteomics Clin Appl 2015; 9: 817-831.
Kawasaki A, Okada M, Tamada A et al. Growth Cone Phosphoproteomics Reveals that GAP-43 Phosphorylated by JNK Is a Marker of Axon Growth and Regeneration. iScience 2018; 4: 190–203.
Kim K, Sirota A, Chen Yh YH et al. Dendrite-like process formation and cytoskeletal remodeling regulated by delta-catenin expression. Exp Cell Res 2002; 275: 171-184.
Grundke-Iqbal I, Iqbal K, Tung YC, Quinlan M, Wisniewski HM, Binder LI. Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci U S A 1986; 83: 4913-4917.
Wang Y, Mandelkow E. Tau in physiology and pathology. Nat Rev Neurosci 2016; 17: 5-21.
Jaworski J, Kapitein LC, Gouveia SM et al. Dynamic microtubules regulate dendritic spine morphology and synaptic plasticity. Neuron 2009; 61: 85-100.
Baines AJ, Lu HC, Bennett PM. The Protein 4.1 family: hub proteins in animals for organizing membrane proteins. Biochim Biophys Acta 2014; 1838: 605–619.
Bennett V, Lorenzo DN. Spectrin- and ankyrin-based membrane domains and the evolution of vertebrates. Curr Top Membr 2013; 72: 1-37.
Kishi M, Pan YA, Crump JG, Sanes JR. Mammalian SAD Kinases Are Required for Neuronal Polarization. Science 2005; 307: 929.
Fuchs E, Karakesisoglou I. Bridging cytoskeletal intersections. Genes Dev 2001; 15: 1-14.
Tymanskyj SR, Yang BH, Verhey KJ, Ma L. MAP7 regulates axon morphogenesis by recruiting kinesin-1 to microtubules and modulating organelle transport. Elife 2018; 7.
Molinie N, Gautreau A. The Arp2/3 Regulatory System and Its Deregulation in Cancer. Physiological Reviews 2017; 98: 215-238.
Hirokawa N, Noda Y, Tanaka Y, Niwa S. Kinesin superfamily motor proteins and intracellular transport. Nat Rev Mol Cell Biol 2009; 10: 682-696.
Morfini G, Schmidt N, Weissmann C, Pigino G, Kins S. Conventional kinesin: Biochemical heterogeneity and functional implications in health and disease. Brain Res Bull 2016; 126: 347-353.
Van Ngo H, Mostowy S. Role of septins in microbial infection. Journal of Cell Science 2019; 132: jcs226266.
Bridges AA, Gladfelter AS. Septin Form and Function at the Cell Cortex. J Biol Chem 2015; 290: 17173-17180.
Arnér ES. Focus on mammalian thioredoxin reductases--important selenoproteins with versatile functions. Biochim Biophys Acta 2009; 1790: 495-526.
Damdimopoulou PE, Miranda-Vizuete A, Arnér ES, Gustafsson JA, Damdimopoulos AE. The human thioredoxin reductase-1 splice variant TXNRD1_v3 is an atypical inducer of cytoplasmic filaments and cell membrane filopodia. Biochim Biophys Acta 2009; 1793: 1588-1596.
Oláh J, Szénási T, Szabó A et al. Tubulin Binding and Polymerization Promoting Properties of Tubulin Polymerization Promoting Proteins Are Evolutionarily Conserved. Biochemistry 2017; 56: 1017-1024.